T1	intervention 0 13	Oral curcumin
T2	condition 18 38	radiation dermatitis
T3	total-participants 62 65	686
T4	control 557 564	placebo
T5	total-participants 644 647	686
T6	eligibility 66 88	breast cancer patients
T7	total-participants 822 825	686
T8	ethinicity 878 883	white
T9	age 904 906	58
T10	outcome 979 1008	radiation dermatitis severity
T11	outcome 1147 1176	trend toward reduced severity
T12	iv-bin-percent 1178 1181	7.4
T13	cv-bin-percent 1186 1191	12.9%
T15	outcome 1361 1390	radiation dermatitis severity
T14	outcome 1233 1237	pain
T16	outcome 1239 1247	symptoms
T17	outcome 1253 1268	quality of life
